Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation® Canada

Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Long COVID.

New Resource Available for People with ME/CFS

Exciting news! The U.S. ME/CFS Clinician Coalition has released new resources for people with ME/CFS to bring to their health care providers for diagnosis, testing, and treatment recommendations.

Read the Coalition Recommendations Announcement here.

The resources include a document on testing recommendations and a document on treatment recommendations to help patients and their healthcare providers with the overall care and management of ME/CFS.

OMFCA’s goal is to empower caregivers and people living with ME/CFS to manage their health today while we search for tomorrow’s answers. We hope you find these new documents to be helpful in navigating the complex world of ME/CFS.

Be sure to also check out OMFCA’s Resource Center! This webpage includes parent resources, information to share with your doctor, general information on ME/CFS, and more. We will continue to share with the community whenever the page has been updated with new, verified information.

About The U.S. ME/CFS Clinician Coalition:

The U.S. ME/CFS Clinician Coalition is a group of U.S. clinical disease experts who have collectively spent hundreds of years treating thousands of ME/CFS patients.

They have authored primers on clinical management, served on CDC medical education initiatives, and are actively involved in ME/CFS research. OMF is proud that Ronald G. Tompkins, MD, ScD, OMF Chief Medical Officer, is one of the U.S. ME/CFS Clinician Coalition members.

If you are able, please consider contributing to our effort to uncover research-based answers.

Help us improve the quality of life for all sufferers of ME/CFS and other chronic complex diseases, such as Post Treatment Lyme Disease Syndrome and Fibromyalgia.